Evelyn Partners Asset Management Ltd
Source: SEC Form 13F · as of Mar 2026Evelyn Partners Asset Management Ltd holds 19 biotech & pharma companies tracked by BioSniper, totaling $18.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$18.0M
| Company | Shares | Value |
|---|---|---|
| ZTSZoetis Inc. | 50,716 | $6.0M |
| JNJJOHNSON & JOHNSON | 17,630 | $4.3M |
| AZNASTRAZENECA PLC | 20,317 | $3.9M |
| NVONovo Nordisk A/S | 36,443 | $1.3M |
| LLYELI LILLY & Co | 1,441 | $1.3M |
| SNYSanofi | 10,414 | $502K |
| ABBVAbbVie Inc. | 1,611 | $350K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 237 | $64K |
| BMYBRISTOL MYERS SQUIBB CO | 764 | $46K |
| PFEPFIZER INC | 1,350 | $38K |
| FHTXFoghorn Therapeutics Inc. | 7,100 | $34K |
| ABTABBOTT LABORATORIES | 322 | $33K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 47 | $21K |
| MRKMerck & Co., Inc. | 118 | $14K |
| MCKMcKesson Corporation | 15 | $13K |
| PMPhilip Morris International Inc | 63 | $10K |
| IDXXIDEXX LABORATORIES INC /DE | 14 | $8K |
| ELVElevance Health Inc. | 12 | $4K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 7 | $130 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.